Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:36 pm Purchase | 2025-01-30 | 13D | Cellectis S.A. CLLS | Bpifrance Participations S.A. | 10,292,653 13.100% | 500,000 (+5.11%) | Filing History |
| 2025-01-24 09:52 am Purchase | 2025-01-23 | 13D | Cellectis S.A. CLLS | AstraZeneca PLC | 44,000,000 44.000% | 28,000,000 (+175.00%) | Filing History |
| 2024-05-21 4:19 pm Unchanged | 2024-05-16 | 13D | Cellectis S.A. CLLS | Bpifrance Participations S.A. | 9,792,653 6.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 5:07 pm Purchase | 2023-12-31 | 13G | Cellectis S.A. CLLS | Long Focus Capital Management LLC | 4,487,293 6.300% | 1,803,660 (+67.21%) | Filing History |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Cellectis S.A. CLLS | PFIZER INC PFE | 2,786,924 3.890% | 2,786,924 (New Position) | Filing History |
| 2023-12-05 07:18 am Sale | 2023-11-30 | 13G | Cellectis S.A. CLLS | BAILLIE GIFFORD & CO | 2,192,757 3.060% | -956,663 (-30.38%) | Filing History |
| 2023-11-16 11:16 am Unchanged | 2023-11-14 | 13D | Cellectis S.A. CLLS | AstraZeneca PLC | 16,000,000 22.400% | 0 (Unchanged) | Filing History |
| 2023-11-13 3:04 pm Purchase | 2023-11-06 | 13D | Cellectis S.A. CLLS | Bpifrance Participations S.A. | 9,792,653 9.700% | 485,656 (+5.22%) | Filing History |
| 2023-11-09 5:07 pm Purchase | 2023-11-01 | 13D | Cellectis S.A. CLLS | AstraZeneca PLC | 16,000,000 22.400% | 16,000,000 (New Position) | Filing History |
| 2023-06-01 2:46 pm Purchase | 2023-05-31 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 2.900% | 0 (+0.00%) | Filing History |
| 2023-02-14 4:02 pm Purchase | 2022-12-31 | 13G | Cellectis S.A. CLLS | Long Focus Capital Management LLC | 2,683,633 5.900% | 141,274 (+5.56%) | Filing History |
| 2023-02-14 12:34 pm Purchase | 2023-02-07 | 13D | Cellectis S.A. CLLS | Bpifrance Participations S.A. | 9,306,997 11.600% | 2,466,110 (+36.05%) | Filing History |
| 2023-01-18 10:03 am Sale | 2022-12-30 | 13G | Cellectis S.A. CLLS | BAILLIE GIFFORD & CO | 3,149,420 6.910% | -1,186,463 (-27.36%) | Filing History |
| 2023-01-17 4:08 pm Unchanged | 2023-01-13 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 49.100% | 0 (Unchanged) | Filing History |
| 2022-11-01 4:30 pm Unchanged | 2022-10-31 | 13D | Calyxt, Inc. CLXT | Cellectis S.A. | 479,264 49.100% | 0 (Unchanged) | Filing History |
| 2022-05-03 2:15 pm Purchase | 2022-03-10 | 13G | Cellectis S.A. CLLS | Long Focus Capital Management LLC | 2,542,359 5.600% | 2,542,359 (New Position) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Cellectis S.A. CLLS | Capital International Investors | 2,173,802 4.800% | -702,669 (-24.43%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | Cellectis S.A. CLLS | ARK Investment Management LLC | 2,941,556 6.470% | -3,737,521 (-55.96%) | Filing History |
| 2022-01-12 06:13 am Purchase | 2021-12-31 | 13G | Cellectis S.A. CLLS | BAILLIE GIFFORD & CO | 4,335,883 9.530% | 4,335,883 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Cellectis S.A. CLLS | ARK Investment Management LLC | 6,679,077 15.720% | 1,815,312 (+37.32%) | Filing History |